.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Medtronic
US Department of Justice
Citi
Novartis
Cipla
Healthtrust
Dow
Chinese Patent Office

Generated: June 22, 2017

DrugPatentWatch Database Preview

FLUDARABINE PHOSPHATE Drug Profile

« Back to Dashboard

What is the patent landscape for Fludarabine Phosphate, and when can generic versions of Fludarabine Phosphate launch?

Fludarabine Phosphate is a drug marketed by Actavis Totowa, Mustafa Nevzat Ilac, Sandoz, Actavis Llc, Fresenius Kabi Usa, Mylan Labs Ltd, Sagent Pharms, and Hospira. and is included in eleven NDAs.

The generic ingredient in FLUDARABINE PHOSPHATE is fludarabine phosphate. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the fludarabine phosphate profile page.

Summary for Tradename: FLUDARABINE PHOSPHATE

Patents:0
Applicants:8
NDAs:11
Suppliers / Packagers: see list9
Bulk Api Vendors: see list48
Clinical Trials: see list1,538
Patent Applications: see list5,822
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLUDARABINE PHOSPHATE at DailyMed

Pharmacology for Tradename: FLUDARABINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION078610-001Feb 11, 2009APRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION200648-001Oct 16, 2012APRXNoNo► Subscribe► Subscribe
Actavis Llc
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION203738-001Feb 28, 2017APRXNoNo► Subscribe► Subscribe
Sagent Pharms
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION076349-001Aug 28, 2003APRXNoNo► Subscribe► Subscribe
Mustafa Nevzat Ilac
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION090724-001Sep 27, 2010APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
QuintilesIMS
Farmers Insurance
McKesson
Boehringer Ingelheim
AstraZeneca
Merck
Federal Trade Commission
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot